These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27307734)

  • 1. Rationally designed nanocarriers for intranasaltherapy of allergic rhinitis: influence of carrier type on in vivo nasal deposition.
    Sallam MA; Helal HM; Mortada SM
    Int J Nanomedicine; 2016; 11():2345-57. PubMed ID: 27307734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and Fate of Nanoparticles Designed for the Nasal Delivery of Poorly Soluble Drugs.
    Clementino AR; Pellegrini G; Banella S; Colombo G; Cantù L; Sonvico F; Del Favero E
    Mol Pharm; 2021 Aug; 18(8):3132-3146. PubMed ID: 34259534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel nasal co-loaded loratadine and sulpiride nanoemulsion with improved downregulation of TNF-α, TGF-β and IL-1 in rabbit models of ovalbumin-induced allergic rhinitis.
    Mohamad SA; Safwat MA; Elrehany M; Maher SA; Badawi AM; Mansour HF
    Drug Deliv; 2021 Dec; 28(1):229-239. PubMed ID: 33501873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Triamcinolone Acetonide-Loaded Nanostructured Lipid Carriers (NLCs) for Buccal Drug Delivery Using the Box-Behnken Design.
    Kraisit P; Sarisuta N
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29690622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local safety of intranasal triamcinolone acetonide: clinical and histological aspects of nasal mucosa in the long-term treatment of perennial allergic rhinitis.
    Klossek JM; Laliberté F; Laliberté MF; Mounedji N; Bousquet J
    Rhinology; 2001 Mar; 39(1):17-22. PubMed ID: 11340690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A risk-benefit assessment of intranasal triamcinolone acetonide in allergic rhinitis.
    Gawchik SM; Saccar CL
    Drug Saf; 2000 Oct; 23(4):309-22. PubMed ID: 11051218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal Morphology Transformation Nanomedicines for Long-Term Intervention of Allergic Rhinitis.
    Teng Z; Yang J; Chen X; Liu Y
    ACS Nano; 2023 Dec; 17(24):25322-25334. PubMed ID: 38088363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal mucosal inflammation has no effect on the absorption of intranasal triamcinolone acetonide.
    Argenti D; Colligon I; Heald D; Ziemniak J
    J Clin Pharmacol; 1994 Aug; 34(8):854-8. PubMed ID: 7962675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers.
    Abdel-Mottaleb MM; Neumann D; Lamprecht A
    Eur J Pharm Biopharm; 2011 Sep; 79(1):36-42. PubMed ID: 21558002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new solution-based intranasal triamcinolone acetonide formulation in patients with perennial allergic rhinitis: how does the pharmacokinetic/pharmacodynamic profile for cortisol suppression compare with an aqueous suspension-based formulation?
    Hochhaus G; González MA; Dockhorn RJ; Shilstone J; Karafilidis J
    J Clin Pharmacol; 2002 Jun; 42(6):662-9. PubMed ID: 12043955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of triamcinolone acetonide aqueous nasal spray in patients with seasonal allergic rhinitis.
    Munk ZM; LaForce C; Furst JA; Simpson B; Feiss G; Smith JA
    Ann Allergy Asthma Immunol; 1996 Oct; 77(4):277-81. PubMed ID: 8885803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route.
    Gabal YM; Kamel AO; Sammour OA; Elshafeey AH
    Int J Pharm; 2014 Oct; 473(1-2):442-57. PubMed ID: 25062866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triamcinolone acetonide-loaded lipid nanocapsules for ophthalmic applications.
    Formica ML; Ullio Gamboa GV; Tártara LI; Luna JD; Benoit JP; Palma SD
    Int J Pharm; 2020 Jan; 573():118795. PubMed ID: 31682964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of lamotrigine containing nanocapsules for nasal administration.
    Gieszinger P; Stefania Csaba N; Garcia-Fuentes M; Prasanna M; Gáspár R; Sztojkov-Ivanov A; Ducza E; Márki Á; Janáky T; Kecskeméti G; Katona G; Szabó-Révész P; Ambrus R
    Eur J Pharm Biopharm; 2020 Aug; 153():177-186. PubMed ID: 32531424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tri-Nasal triamcinolone acetonide nasal spray 200 and 400 micrograms qd versus placebo and Nasacort triamcinolone acetonide nasal aerosol 440 micrograms qd in patients suffering from seasonal allergic rhinitis during the grass season.
    Rosenthal R; Berger W; Bronsky E; Dockhorn R; Korenblat P; Lampl K; Lumry W; Pollard S; Raphael G; Rohr C; Shapiro G; Valentine M; Wanderer A; Fleming L; LaVallee N; Stepanians M; Karafilidis J; Shilstone J; Ellis E
    Am J Rhinol; 1998; 12(6):427-33. PubMed ID: 9883300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superiority of TPGS-loaded micelles in the brain delivery of vinpocetine via administration of thermosensitive intranasal gel.
    Ahmed TA; El-Say KM; Ahmed OA; Aljaeid BM
    Int J Nanomedicine; 2019; 14():5555-5567. PubMed ID: 31413562
    [No Abstract]   [Full Text] [Related]  

  • 17. [Animal experimental study of effects of long-term triamcinolone acetonide acetate nasal spray on the nasal mucosa].
    Zhai S; Cao J; Sun J; Yang W
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2002 May; 16(5):232-3. PubMed ID: 12592664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release profile and transscleral permeation of triamcinolone acetonide loaded nanostructured lipid carriers (TA-NLC): in vitro and ex vivo studies.
    Araújo J; Garcia ML; Mallandrich M; Souto EB; Calpena AC
    Nanomedicine; 2012 Aug; 8(6):1034-41. PubMed ID: 22115598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological effects of intranasal phototherapy and nasal corticosteroids in allergic rhinitis in a rabbit model.
    Yurttas V; Şereflican M; Erkoçoğlu M; Terzi EH; Kükner A; Oral M
    J Photochem Photobiol B; 2015 Aug; 149():289-91. PubMed ID: 26123190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled, controlled antigen delivery study of the onset of action of aerosolized triamcinolone acetonide nasal spray in subjects with ragweed-induced allergic rhinitis.
    Day JH; Buckeridge DL; Clark RH; Briscoe MP; Phillips R
    J Allergy Clin Immunol; 1996 May; 97(5):1050-7. PubMed ID: 8626981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.